Prashant Grover
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Prashant Grover has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Anil Magge
University of Connecticut, Farmington, CT
1 shared publication- Kenda Alkwatli
Endocrinology Starling Physicians Wethersfield Connecticut USA
1 shared publication - Misbah Azmath
Division of Endocrinology, Diabetes and Metabolism, University of Connecticut School of Medicine , Farmington, CT 06032 , USA
1 shared publication - Pooja Luthra
University of Connecticut School of Medicine
1 shared publication - Rahul Mutneja
Department of Pulmonary and Critical Care Medicine, Saint Francis Hospital and Medical Center, Hartford, Connecticut, USA
1 shared publication Ricardo Perez
University of Connecticut, Pulmonary Critical Care Fellowship Program, Farmington, CT
1 shared publication
Latest Publications
- Open Access
- 1 July 2023
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 1 (4) , luad053
Refractory Thyroid Storm Due to Graves Disease in a Patient With Thymic Lymphoepithelial Carcinoma
Thyroid storm is a life-threatening endocrine emergency that warrants early clinical recognition and aggressive intervention. We present a 64-year-old female with no known history of thyroid disease, who presented to her primary care physician with dyspnea on exertion and was found to have an anterior mediastinal mass. She had elective thymectomy. Pathology confirmed thymic lymphoepithelial carcinoma. Postoperatively, she developed altered mental status, fever, and atrial fibrillation with marked elevation of thyroid hormones, consistent with thyroid storm. She decompensated rapidly and was treated aggressively with standard therapies for thyroid storm, including beta-blockers, methimazole, cholestyramine, steroids, and iodine, with poor response. The patient eventually underwent 4 sessions of therapeutic plasma exchange (TPE) with marked improvement in her symptoms. This case reports a possible association between thymic lymphoepithelial carcinoma and Graves disease and highlights the utility of TPE in cases of severe thyroid storm that are refractory to traditional treatments. We learn from this case that evaluating thyroid function tests in patients with thymic or mediastinal masses before surgery might be helpful. TPE should be considered in patients with thyroid storm refractory to traditional therapies.
- 1 July 2023
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 1 (4) , luad053
Open AccessRefractory Thyroid Storm Due to Graves Disease in a Patient With Thymic Lymphoepithelial Carcinoma
Thyroid storm is a life-threatening endocrine emergency that warrants early clinical recognition and aggressive intervention. We present a 64-year-old female with no known history of thyroid disease, who presented to her primary care physician with dyspnea on exertion and was found to have an anterior mediastinal mass. She had elective thymectomy. Pathology confirmed thymic lymphoepithelial carcinoma. Postoperatively, she developed altered mental status, fever, and atrial fibrillation with marked elevation of thyroid hormones, consistent with thyroid storm. She decompensated rapidly and was treated aggressively with standard therapies for thyroid storm, including beta-blockers, methimazole, cholestyramine, steroids, and iodine, with poor response. The patient eventually underwent 4 sessions of therapeutic plasma exchange (TPE) with marked improvement in her symptoms. This case reports a possible association between thymic lymphoepithelial carcinoma and Graves disease and highlights the utility of TPE in cases of severe thyroid storm that are refractory to traditional treatments. We learn from this case that evaluating thyroid function tests in patients with thymic or mediastinal masses before surgery might be helpful. TPE should be considered in patients with thyroid storm refractory to traditional therapies.
- Open Access
Chronic Thromboembolic Pulmonary Hypertension in the Setting of Essential Thrombocytosis